share_log

BioNTech | 6-K: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union

BioNTech | 6-K: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union

BioNTech | 6-K:辉瑞和BioNTech的Omicron JN.1适应型COVID-19疫苗在欧盟获得CHMP积极评价
美股SEC公告 ·  06/28 16:10
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息